Centogene
What They Do
Rare disease diagnostics and multiomic data platform leveraging AI for genetic insights. Maintains one of the world's largest rare disease datasets.
Funding
Valuation: Sold operating assets for €8.7M (2025); was Nasdaq-listed Publicly listed (Nasdaq: CNTG)